home / stock / atrc / atrc quote
Last: | $23.39 |
---|---|
Change Percent: | 0.34% |
Open: | $23.37 |
Close: | $23.39 |
High: | $23.69 |
Low: | $22.87 |
Volume: | 976,148 |
Last Trade Date Time: | 04/18/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$23.39 | $23.37 | $23.39 | $23.69 | $22.87 | 976,148 | 04-18-2024 |
$23.45 | $23.19 | $23.45 | $24.01 | $23.135 | 1,057,560 | 04-17-2024 |
$23.1 | $22.75 | $23.1 | $23.35 | $22.415 | 1,111,445 | 04-16-2024 |
$22.9 | $24.35 | $22.9 | $24.515 | $22.48 | 1,315,355 | 04-15-2024 |
$24.09 | $24.96 | $24.09 | $24.97 | $23.71 | 561,606 | 04-12-2024 |
$25.31 | $26.09 | $25.31 | $26.27 | $25.2 | 582,084 | 04-11-2024 |
$25.9 | $26.59 | $25.9 | $27.25 | $25.76 | 740,516 | 04-10-2024 |
$27.61 | $26.63 | $27.61 | $27.63 | $26.5 | 1,011,112 | 04-09-2024 |
$26.54 | $26.41 | $26.54 | $26.68 | $26.12 | 751,062 | 04-08-2024 |
$26.26 | $26.07 | $26.26 | $26.55 | $25.95 | 510,667 | 04-05-2024 |
$26.15 | $26.8 | $26.15 | $27.055 | $25.83 | 784,231 | 04-04-2024 |
$26.48 | $26.85 | $26.48 | $26.96 | $26.145 | 989,473 | 04-03-2024 |
$27.21 | $28.65 | $27.21 | $29.06 | $26.92 | 549,535 | 04-02-2024 |
$29.09 | $30.39 | $29.09 | $30.39 | $28.77 | 569,737 | 04-01-2024 |
$30.42 | $30 | $30.42 | $30.58 | $29.61 | 542,166 | 03-29-2024 |
$30.42 | $30 | $30.42 | $30.58 | $29.61 | 542,166 | 03-28-2024 |
$30.14 | $29.54 | $30.14 | $30.47 | $29.09 | 841,359 | 03-27-2024 |
$29.09 | $28.54 | $29.09 | $29.15 | $28.07 | 602,258 | 03-26-2024 |
$28.21 | $28.62 | $28.21 | $29.125 | $27.92 | 746,418 | 03-25-2024 |
$28.47 | $29.91 | $28.47 | $29.91 | $28.21 | 965,555 | 03-22-2024 |
News, Short Squeeze, Breakout and More Instantly...
AtriCure, Inc. ( Nasdaq: ATRC ), a leading innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management, today announced that it has launched the cryoSPHERE ® + cryoablation probe, leve...
AtriCure, Inc. ( Nasdaq: ATRC ), a leading innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management, today announced that it will release its first quarter 2024 financial results on Wednesday, M...
A look at the top 10 most actives in the United States Kintara Therapeutics Inc. (KTRA) rose 99.9% to $0.2007 on volume of 121,318,217 shares Next.e.GO N.V. (EGOX) rose 30.8% to $0.034 on volume of 63,981,361 shares C3is Inc. (CISS) rose 20.8% to $0.0494 on volume of 63,446,681 shares I...